Stem Cell and Gene Therapy Innovations Poised to Transform Medicine
The global stem cell market, valued at $15.10 billion in 2024, is on a trajectory to nearly double to $28.89 billion by 2030, growing at...
Avenue Z Recognized for Pioneering AI Search Optimization Solution
Avenue Z has been awarded the Cognitive Communications Solution of the Year by the AI Breakthrough Awards for its innovative AI Optimization (AIO) Solution. This...
Study Reveals Growing Disconnect Between Employee Mental Health Needs and Workplace Support
A recent study by the HR.com Research Institute, titled ‘HR.com’s State of Employee Mental Health & Stress in the Workplace 2025’, sheds light on a...
Neutra Corp Achieves Positive Cash Flow in Q1 2025 Following Expansion of Clinical Research Network
Neutra Life Sciences, a subsidiary of Neutra Corp (OTC: NTRR), has announced a promising start to its operations in the first quarter of 2025, achieving...
Trillion Energy International Inc. Settles $386K Debt Through Share Issuance
Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) has announced a strategic move to settle $386,295.42 in debt by issuing 7,725,908 common shares at $0.05...
Congo’s Extended Cobalt Export Ban Fails to Boost Global Prices
The Democratic Republic of Congo (DRC), the world’s largest producer of cobalt, has extended its moratorium on cobalt exports for another three months, a move...
Tonix Pharmaceuticals Added to Russell 3000 and Russell 2000 Indexes
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) has been added to the Russell 3000® and Russell 2000® Indexes, a move that underscores the company’s growing market...
Hucke Exteriors Secures ‘Best of the Best’ Roofing Award in Wisconsin for Second Consecutive Year
Hucke Exteriors, a Brookfield-based roofing and siding company, has been honored with the ‘Best of the Best’ award for the second consecutive year, a testament...
Quantum BioPharma Ltd. Announces $600 Private Placement to Support Innovative Biotech Research
Quantum BioPharma Ltd. (NASDAQ: QNTM), a biopharmaceutical company at the forefront of developing innovative treatments for challenging neurodegenerative and metabolic disorders, has announced a non-brokered...